22 related articles for article (PubMed ID: 6574914)
1. Impaired local natural killer cell activity in human colorectal carcinomas.
Aparicio-Pagés NM; Verspaget HW; Peña SA; Lamers CB
Cancer Immunol Immunother; 1989; 28(4):301-4. PubMed ID: 2495180
[TBL] [Abstract][Full Text] [Related]
2. Divergence in activation by poly I:C of human natural killer and killer cells.
Edwards BS; Borden EC; Smith-Zaremba K
Cancer Immunol Immunother; 1982; 13(3):158-63. PubMed ID: 6925981
[TBL] [Abstract][Full Text] [Related]
3. Biology of natural killer cells.
Trinchieri G
Adv Immunol; 1989; 47():187-376. PubMed ID: 2683611
[TBL] [Abstract][Full Text] [Related]
4. Inverse relationship between interferon production by mononuclear leucocytes and oxidative metabolism of neutrophil granulocytes in infection prone children.
Bondestam M; Funa K; Venge P; Alm GV
Clin Exp Immunol; 1985 Apr; 60(1):196-202. PubMed ID: 2408797
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of responses measured by natural cytotoxicity and chemiluminescence.
Ernst M; Lange A; Flad HD; Havel A; Ennen J; Ulmer AJ
Eur J Immunol; 1984 Jul; 14(7):634-9. PubMed ID: 6430710
[TBL] [Abstract][Full Text] [Related]
6. Tumor-activated NK cells trigger monocyte oxidative metabolism.
Pohajdak B; Gomez JL; Wilkins JA; Greenberg AH
J Immunol; 1984 Nov; 133(5):2430-6. PubMed ID: 6434630
[TBL] [Abstract][Full Text] [Related]
7. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
8. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.
Leiden JM; Karpinski BA; Gottschalk L; Kornbluth J
J Immunol; 1989 Mar; 142(6):2140-7. PubMed ID: 2493507
[TBL] [Abstract][Full Text] [Related]
10. The chemiluminescence response of human natural killer cells. II. Association of a decreased response with low natural killer activity.
Werkmeister J; Helfand S; Roder J; Pross H
Eur J Immunol; 1983 Jun; 13(6):514-20. PubMed ID: 6574914
[TBL] [Abstract][Full Text] [Related]
11. From the "missing self" hypothesis to adaptive NK cells: Insights of NK cell-mediated effector functions in immune surveillance.
Cruz-Muñoz ME; Valenzuela-Vázquez L; Sánchez-Herrera J; Santa-Olalla Tapia J
J Leukoc Biol; 2019 May; 105(5):955-971. PubMed ID: 30848847
[TBL] [Abstract][Full Text] [Related]
12. Human NK cells in health and disease: clinical, functional, phenotypic and DNA genotypic characteristics.
Richards SJ; Scott CS
Leuk Lymphoma; 1992 Aug; 7(5-6):377-99. PubMed ID: 1493440
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
